Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Aurobindo > September 23, 2009

      Aurobindo Gets US FDA nod


      Aurobindo Pharma Limited has received the tentative approval for Atomoxetine Hydrochloride capsules in 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg strengths.

      The company has also received final approvals for Ribavirin tablets 200mg and Ribavirin capsules 200 mg from the US Food and Drug Adminsitration.

      Atomoxetine Hydrochloride capsules are generic equivalent to Strattera of Eli Lily and Company. Aurobindo shares 180 days exclusivity with other generic companies subject to the final approval and launch based on the pending litigation with Eli Lily, a company release said.

      These tablets, which come under neurological segment, are used in treatment of attention deficiency and hyperactivity in children. The product had a market size of approximately $500 million (Rs 2,450 crore) for the 12 months ending March 2009.

      Ribavirin tablets are generic equivalent to Copegus tablets of Hoffman La Roche Inc and Ribavirin capsules are generic equivalent to Rebetol capsules of Schering Corporation.

      Ribavirin tablets and capsules are antiviral agents and are useful intreatment of chronic hepatitis C virus. The products had a market size of approximately $90 million (Rs 441 crore) for the 12 months ending March 2009 and will be launched shortly, the release added.

      September 23, 2009


      Share this Article!

    Back to top^